nodes	percent_of_prediction	percent_of_DWPC	metapath
Olmesartan—SLCO1B3—Methotrexate—testicular cancer	0.131	0.168	CbGbCtD
Olmesartan—ABCC2—Carboplatin—testicular cancer	0.12	0.155	CbGbCtD
Olmesartan—ABCC2—Vinblastine—testicular cancer	0.112	0.144	CbGbCtD
Olmesartan—ABCC2—Cisplatin—testicular cancer	0.103	0.132	CbGbCtD
Olmesartan—ABCC2—Etoposide—testicular cancer	0.101	0.13	CbGbCtD
Olmesartan—SLCO1B1—Methotrexate—testicular cancer	0.076	0.0976	CbGbCtD
Olmesartan—ABCC2—Doxorubicin—testicular cancer	0.069	0.0885	CbGbCtD
Olmesartan—ABCC2—Methotrexate—testicular cancer	0.0668	0.0858	CbGbCtD
Olmesartan—Upper respiratory tract infection—Epirubicin—testicular cancer	0.000268	0.00121	CcSEcCtD
Olmesartan—Influenza—Doxorubicin—testicular cancer	0.000267	0.00121	CcSEcCtD
Olmesartan—Asthenia—Ifosfamide—testicular cancer	0.000266	0.0012	CcSEcCtD
Olmesartan—Eosinophilia—Doxorubicin—testicular cancer	0.000264	0.0012	CcSEcCtD
Olmesartan—Photosensitivity reaction—Epirubicin—testicular cancer	0.000263	0.00119	CcSEcCtD
Olmesartan—Feeling abnormal—Cisplatin—testicular cancer	0.000263	0.00119	CcSEcCtD
Olmesartan—Pruritus—Ifosfamide—testicular cancer	0.000262	0.00119	CcSEcCtD
Olmesartan—Haematuria—Methotrexate—testicular cancer	0.000262	0.00119	CcSEcCtD
Olmesartan—Pancreatitis—Doxorubicin—testicular cancer	0.000262	0.00118	CcSEcCtD
Olmesartan—Hyperglycaemia—Epirubicin—testicular cancer	0.00026	0.00118	CcSEcCtD
Olmesartan—Angina pectoris—Doxorubicin—testicular cancer	0.00026	0.00118	CcSEcCtD
Olmesartan—Pneumonia—Epirubicin—testicular cancer	0.000259	0.00117	CcSEcCtD
Olmesartan—Nausea—Bleomycin—testicular cancer	0.000257	0.00116	CcSEcCtD
Olmesartan—Infestation NOS—Epirubicin—testicular cancer	0.000257	0.00116	CcSEcCtD
Olmesartan—Infestation—Epirubicin—testicular cancer	0.000257	0.00116	CcSEcCtD
Olmesartan—Vomiting—Dactinomycin—testicular cancer	0.000257	0.00116	CcSEcCtD
Olmesartan—Bronchitis—Doxorubicin—testicular cancer	0.000257	0.00116	CcSEcCtD
Olmesartan—Agranulocytosis—Methotrexate—testicular cancer	0.000256	0.00116	CcSEcCtD
Olmesartan—Rash—Dactinomycin—testicular cancer	0.000255	0.00115	CcSEcCtD
Olmesartan—Decreased appetite—Etoposide—testicular cancer	0.000254	0.00115	CcSEcCtD
Olmesartan—Diarrhoea—Ifosfamide—testicular cancer	0.000253	0.00115	CcSEcCtD
Olmesartan—Pancytopenia—Doxorubicin—testicular cancer	0.000253	0.00115	CcSEcCtD
Olmesartan—Renal failure—Epirubicin—testicular cancer	0.000253	0.00114	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Etoposide—testicular cancer	0.000253	0.00114	CcSEcCtD
Olmesartan—Body temperature increased—Cisplatin—testicular cancer	0.000252	0.00114	CcSEcCtD
Olmesartan—Fatigue—Etoposide—testicular cancer	0.000252	0.00114	CcSEcCtD
Olmesartan—Jaundice—Epirubicin—testicular cancer	0.000251	0.00113	CcSEcCtD
Olmesartan—Pain—Etoposide—testicular cancer	0.00025	0.00113	CcSEcCtD
Olmesartan—Constipation—Etoposide—testicular cancer	0.00025	0.00113	CcSEcCtD
Olmesartan—Urinary tract infection—Epirubicin—testicular cancer	0.00025	0.00113	CcSEcCtD
Olmesartan—Neutropenia—Doxorubicin—testicular cancer	0.000249	0.00113	CcSEcCtD
Olmesartan—Upper respiratory tract infection—Doxorubicin—testicular cancer	0.000248	0.00112	CcSEcCtD
Olmesartan—Haematuria—Epirubicin—testicular cancer	0.000245	0.00111	CcSEcCtD
Olmesartan—Dizziness—Ifosfamide—testicular cancer	0.000245	0.00111	CcSEcCtD
Olmesartan—Pharyngitis—Methotrexate—testicular cancer	0.000245	0.00111	CcSEcCtD
Olmesartan—Urinary tract disorder—Methotrexate—testicular cancer	0.000244	0.0011	CcSEcCtD
Olmesartan—Photosensitivity reaction—Doxorubicin—testicular cancer	0.000244	0.0011	CcSEcCtD
Olmesartan—Urethral disorder—Methotrexate—testicular cancer	0.000242	0.00109	CcSEcCtD
Olmesartan—Sinusitis—Epirubicin—testicular cancer	0.000241	0.00109	CcSEcCtD
Olmesartan—Feeling abnormal—Etoposide—testicular cancer	0.000241	0.00109	CcSEcCtD
Olmesartan—Hyperglycaemia—Doxorubicin—testicular cancer	0.000241	0.00109	CcSEcCtD
Olmesartan—Nausea—Dactinomycin—testicular cancer	0.00024	0.00109	CcSEcCtD
Olmesartan—Agranulocytosis—Epirubicin—testicular cancer	0.00024	0.00109	CcSEcCtD
Olmesartan—Pneumonia—Doxorubicin—testicular cancer	0.000239	0.00108	CcSEcCtD
Olmesartan—Gastrointestinal pain—Etoposide—testicular cancer	0.000239	0.00108	CcSEcCtD
Olmesartan—Infestation NOS—Doxorubicin—testicular cancer	0.000238	0.00108	CcSEcCtD
Olmesartan—Infestation—Doxorubicin—testicular cancer	0.000238	0.00108	CcSEcCtD
Olmesartan—Vomiting—Ifosfamide—testicular cancer	0.000235	0.00107	CcSEcCtD
Olmesartan—Renal failure—Doxorubicin—testicular cancer	0.000234	0.00106	CcSEcCtD
Olmesartan—Rash—Ifosfamide—testicular cancer	0.000233	0.00106	CcSEcCtD
Olmesartan—Dermatitis—Ifosfamide—testicular cancer	0.000233	0.00106	CcSEcCtD
Olmesartan—Urticaria—Etoposide—testicular cancer	0.000232	0.00105	CcSEcCtD
Olmesartan—Jaundice—Doxorubicin—testicular cancer	0.000232	0.00105	CcSEcCtD
Olmesartan—Rhinitis—Epirubicin—testicular cancer	0.000231	0.00105	CcSEcCtD
Olmesartan—Abdominal pain—Etoposide—testicular cancer	0.000231	0.00105	CcSEcCtD
Olmesartan—Body temperature increased—Etoposide—testicular cancer	0.000231	0.00105	CcSEcCtD
Olmesartan—Urinary tract infection—Doxorubicin—testicular cancer	0.000231	0.00105	CcSEcCtD
Olmesartan—Asthenia—Cisplatin—testicular cancer	0.000229	0.00104	CcSEcCtD
Olmesartan—Pharyngitis—Epirubicin—testicular cancer	0.000229	0.00104	CcSEcCtD
Olmesartan—Urinary tract disorder—Epirubicin—testicular cancer	0.000228	0.00103	CcSEcCtD
Olmesartan—Oedema peripheral—Epirubicin—testicular cancer	0.000227	0.00103	CcSEcCtD
Olmesartan—Haematuria—Doxorubicin—testicular cancer	0.000227	0.00103	CcSEcCtD
Olmesartan—Connective tissue disorder—Epirubicin—testicular cancer	0.000227	0.00103	CcSEcCtD
Olmesartan—Urethral disorder—Epirubicin—testicular cancer	0.000226	0.00102	CcSEcCtD
Olmesartan—Angiopathy—Methotrexate—testicular cancer	0.000224	0.00101	CcSEcCtD
Olmesartan—Sinusitis—Doxorubicin—testicular cancer	0.000223	0.00101	CcSEcCtD
Olmesartan—Mediastinal disorder—Methotrexate—testicular cancer	0.000222	0.00101	CcSEcCtD
Olmesartan—Agranulocytosis—Doxorubicin—testicular cancer	0.000222	0.001	CcSEcCtD
Olmesartan—Nausea—Ifosfamide—testicular cancer	0.00022	0.000995	CcSEcCtD
Olmesartan—Diarrhoea—Cisplatin—testicular cancer	0.000218	0.000988	CcSEcCtD
Olmesartan—Alopecia—Methotrexate—testicular cancer	0.000218	0.000986	CcSEcCtD
Olmesartan—Mental disorder—Methotrexate—testicular cancer	0.000216	0.000978	CcSEcCtD
Olmesartan—Malnutrition—Methotrexate—testicular cancer	0.000215	0.000971	CcSEcCtD
Olmesartan—Rhinitis—Doxorubicin—testicular cancer	0.000214	0.000969	CcSEcCtD
Olmesartan—Pharyngitis—Doxorubicin—testicular cancer	0.000212	0.000959	CcSEcCtD
Olmesartan—Urinary tract disorder—Doxorubicin—testicular cancer	0.000211	0.000954	CcSEcCtD
Olmesartan—Oedema peripheral—Doxorubicin—testicular cancer	0.00021	0.000952	CcSEcCtD
Olmesartan—Asthenia—Etoposide—testicular cancer	0.00021	0.00095	CcSEcCtD
Olmesartan—Connective tissue disorder—Doxorubicin—testicular cancer	0.00021	0.000949	CcSEcCtD
Olmesartan—Angiopathy—Epirubicin—testicular cancer	0.000209	0.000947	CcSEcCtD
Olmesartan—Urethral disorder—Doxorubicin—testicular cancer	0.000209	0.000947	CcSEcCtD
Olmesartan—Mediastinal disorder—Epirubicin—testicular cancer	0.000208	0.000941	CcSEcCtD
Olmesartan—Back pain—Methotrexate—testicular cancer	0.000208	0.00094	CcSEcCtD
Olmesartan—Pruritus—Etoposide—testicular cancer	0.000207	0.000936	CcSEcCtD
Olmesartan—Arrhythmia—Epirubicin—testicular cancer	0.000206	0.000933	CcSEcCtD
Olmesartan—Alopecia—Epirubicin—testicular cancer	0.000204	0.000923	CcSEcCtD
Olmesartan—Vomiting—Cisplatin—testicular cancer	0.000203	0.000919	CcSEcCtD
Olmesartan—Vision blurred—Methotrexate—testicular cancer	0.000202	0.000915	CcSEcCtD
Olmesartan—Mental disorder—Epirubicin—testicular cancer	0.000202	0.000915	CcSEcCtD
Olmesartan—Rash—Cisplatin—testicular cancer	0.000201	0.000911	CcSEcCtD
Olmesartan—Dermatitis—Cisplatin—testicular cancer	0.000201	0.00091	CcSEcCtD
Olmesartan—Malnutrition—Epirubicin—testicular cancer	0.000201	0.000909	CcSEcCtD
Olmesartan—Diarrhoea—Etoposide—testicular cancer	0.0002	0.000906	CcSEcCtD
Olmesartan—Ill-defined disorder—Methotrexate—testicular cancer	0.000199	0.000901	CcSEcCtD
Olmesartan—Anaemia—Methotrexate—testicular cancer	0.000198	0.000898	CcSEcCtD
Olmesartan—Back pain—Epirubicin—testicular cancer	0.000194	0.000879	CcSEcCtD
Olmesartan—Angiopathy—Doxorubicin—testicular cancer	0.000194	0.000877	CcSEcCtD
Olmesartan—Malaise—Methotrexate—testicular cancer	0.000194	0.000876	CcSEcCtD
Olmesartan—Dizziness—Etoposide—testicular cancer	0.000193	0.000875	CcSEcCtD
Olmesartan—Muscle spasms—Epirubicin—testicular cancer	0.000193	0.000874	CcSEcCtD
Olmesartan—Vertigo—Methotrexate—testicular cancer	0.000193	0.000873	CcSEcCtD
Olmesartan—Mediastinal disorder—Doxorubicin—testicular cancer	0.000192	0.000871	CcSEcCtD
Olmesartan—Leukopenia—Methotrexate—testicular cancer	0.000192	0.000869	CcSEcCtD
Olmesartan—Arrhythmia—Doxorubicin—testicular cancer	0.000191	0.000863	CcSEcCtD
Olmesartan—Nausea—Cisplatin—testicular cancer	0.00019	0.000858	CcSEcCtD
Olmesartan—Vision blurred—Epirubicin—testicular cancer	0.000189	0.000857	CcSEcCtD
Olmesartan—Alopecia—Doxorubicin—testicular cancer	0.000189	0.000854	CcSEcCtD
Olmesartan—Cough—Methotrexate—testicular cancer	0.000187	0.000848	CcSEcCtD
Olmesartan—Mental disorder—Doxorubicin—testicular cancer	0.000187	0.000846	CcSEcCtD
Olmesartan—Ill-defined disorder—Epirubicin—testicular cancer	0.000186	0.000843	CcSEcCtD
Olmesartan—Vomiting—Etoposide—testicular cancer	0.000186	0.000841	CcSEcCtD
Olmesartan—Malnutrition—Doxorubicin—testicular cancer	0.000186	0.000841	CcSEcCtD
Olmesartan—Anaemia—Epirubicin—testicular cancer	0.000186	0.00084	CcSEcCtD
Olmesartan—Agitation—Epirubicin—testicular cancer	0.000185	0.000835	CcSEcCtD
Olmesartan—Rash—Etoposide—testicular cancer	0.000184	0.000834	CcSEcCtD
Olmesartan—Dermatitis—Etoposide—testicular cancer	0.000184	0.000834	CcSEcCtD
Olmesartan—Headache—Etoposide—testicular cancer	0.000183	0.000829	CcSEcCtD
Olmesartan—Myalgia—Methotrexate—testicular cancer	0.000183	0.000827	CcSEcCtD
Olmesartan—Arthralgia—Methotrexate—testicular cancer	0.000183	0.000827	CcSEcCtD
Olmesartan—Chest pain—Methotrexate—testicular cancer	0.000183	0.000827	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—testicular cancer	0.000181	0.000821	CcSEcCtD
Olmesartan—Malaise—Epirubicin—testicular cancer	0.000181	0.00082	CcSEcCtD
Olmesartan—Discomfort—Methotrexate—testicular cancer	0.000181	0.000817	CcSEcCtD
Olmesartan—Vertigo—Epirubicin—testicular cancer	0.00018	0.000817	CcSEcCtD
Olmesartan—Syncope—Epirubicin—testicular cancer	0.00018	0.000815	CcSEcCtD
Olmesartan—Leukopenia—Epirubicin—testicular cancer	0.00018	0.000814	CcSEcCtD
Olmesartan—Back pain—Doxorubicin—testicular cancer	0.00018	0.000814	CcSEcCtD
Olmesartan—Muscle spasms—Doxorubicin—testicular cancer	0.000179	0.000809	CcSEcCtD
Olmesartan—Palpitations—Epirubicin—testicular cancer	0.000178	0.000803	CcSEcCtD
Olmesartan—Loss of consciousness—Epirubicin—testicular cancer	0.000177	0.000799	CcSEcCtD
Olmesartan—Cough—Epirubicin—testicular cancer	0.000175	0.000793	CcSEcCtD
Olmesartan—Anaphylactic shock—Methotrexate—testicular cancer	0.000175	0.000793	CcSEcCtD
Olmesartan—Vision blurred—Doxorubicin—testicular cancer	0.000175	0.000793	CcSEcCtD
Olmesartan—Infection—Methotrexate—testicular cancer	0.000174	0.000788	CcSEcCtD
Olmesartan—Nausea—Etoposide—testicular cancer	0.000174	0.000786	CcSEcCtD
Olmesartan—Ill-defined disorder—Doxorubicin—testicular cancer	0.000172	0.00078	CcSEcCtD
Olmesartan—Nervous system disorder—Methotrexate—testicular cancer	0.000172	0.000777	CcSEcCtD
Olmesartan—Anaemia—Doxorubicin—testicular cancer	0.000172	0.000777	CcSEcCtD
Olmesartan—Thrombocytopenia—Methotrexate—testicular cancer	0.000172	0.000776	CcSEcCtD
Olmesartan—Arthralgia—Epirubicin—testicular cancer	0.000171	0.000774	CcSEcCtD
Olmesartan—Myalgia—Epirubicin—testicular cancer	0.000171	0.000774	CcSEcCtD
Olmesartan—Chest pain—Epirubicin—testicular cancer	0.000171	0.000774	CcSEcCtD
Olmesartan—Agitation—Doxorubicin—testicular cancer	0.000171	0.000773	CcSEcCtD
Olmesartan—Anxiety—Epirubicin—testicular cancer	0.00017	0.000771	CcSEcCtD
Olmesartan—Skin disorder—Methotrexate—testicular cancer	0.00017	0.00077	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—testicular cancer	0.00017	0.000769	CcSEcCtD
Olmesartan—Hyperhidrosis—Methotrexate—testicular cancer	0.000169	0.000766	CcSEcCtD
Olmesartan—Discomfort—Epirubicin—testicular cancer	0.000169	0.000765	CcSEcCtD
Olmesartan—Malaise—Doxorubicin—testicular cancer	0.000168	0.000758	CcSEcCtD
Olmesartan—Vertigo—Doxorubicin—testicular cancer	0.000167	0.000756	CcSEcCtD
Olmesartan—Anorexia—Methotrexate—testicular cancer	0.000167	0.000756	CcSEcCtD
Olmesartan—Syncope—Doxorubicin—testicular cancer	0.000167	0.000754	CcSEcCtD
Olmesartan—Leukopenia—Doxorubicin—testicular cancer	0.000166	0.000753	CcSEcCtD
Olmesartan—Palpitations—Doxorubicin—testicular cancer	0.000164	0.000743	CcSEcCtD
Olmesartan—Oedema—Epirubicin—testicular cancer	0.000164	0.000742	CcSEcCtD
Olmesartan—Anaphylactic shock—Epirubicin—testicular cancer	0.000164	0.000742	CcSEcCtD
Olmesartan—Hypotension—Methotrexate—testicular cancer	0.000164	0.000741	CcSEcCtD
Olmesartan—Loss of consciousness—Doxorubicin—testicular cancer	0.000163	0.000739	CcSEcCtD
Olmesartan—Infection—Epirubicin—testicular cancer	0.000163	0.000737	CcSEcCtD
Olmesartan—Cough—Doxorubicin—testicular cancer	0.000162	0.000734	CcSEcCtD
Olmesartan—Shock—Epirubicin—testicular cancer	0.000161	0.00073	CcSEcCtD
Olmesartan—Nervous system disorder—Epirubicin—testicular cancer	0.000161	0.000728	CcSEcCtD
Olmesartan—Thrombocytopenia—Epirubicin—testicular cancer	0.000161	0.000726	CcSEcCtD
Olmesartan—Tachycardia—Epirubicin—testicular cancer	0.00016	0.000724	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Methotrexate—testicular cancer	0.00016	0.000722	CcSEcCtD
Olmesartan—Skin disorder—Epirubicin—testicular cancer	0.000159	0.000721	CcSEcCtD
Olmesartan—Hyperhidrosis—Epirubicin—testicular cancer	0.000158	0.000717	CcSEcCtD
Olmesartan—Insomnia—Methotrexate—testicular cancer	0.000158	0.000717	CcSEcCtD
Olmesartan—Arthralgia—Doxorubicin—testicular cancer	0.000158	0.000716	CcSEcCtD
Olmesartan—Chest pain—Doxorubicin—testicular cancer	0.000158	0.000716	CcSEcCtD
Olmesartan—Myalgia—Doxorubicin—testicular cancer	0.000158	0.000716	CcSEcCtD
Olmesartan—Anxiety—Doxorubicin—testicular cancer	0.000158	0.000714	CcSEcCtD
Olmesartan—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—testicular cancer	0.000157	0.000711	CcSEcCtD
Olmesartan—Discomfort—Doxorubicin—testicular cancer	0.000156	0.000707	CcSEcCtD
Olmesartan—Anorexia—Epirubicin—testicular cancer	0.000156	0.000707	CcSEcCtD
Olmesartan—Dyspepsia—Methotrexate—testicular cancer	0.000154	0.000698	CcSEcCtD
Olmesartan—Hypotension—Epirubicin—testicular cancer	0.000153	0.000693	CcSEcCtD
Olmesartan—Decreased appetite—Methotrexate—testicular cancer	0.000152	0.000689	CcSEcCtD
Olmesartan—Anaphylactic shock—Doxorubicin—testicular cancer	0.000152	0.000686	CcSEcCtD
Olmesartan—Oedema—Doxorubicin—testicular cancer	0.000152	0.000686	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Methotrexate—testicular cancer	0.000151	0.000684	CcSEcCtD
Olmesartan—Fatigue—Methotrexate—testicular cancer	0.000151	0.000683	CcSEcCtD
Olmesartan—Infection—Doxorubicin—testicular cancer	0.000151	0.000682	CcSEcCtD
Olmesartan—Pain—Methotrexate—testicular cancer	0.00015	0.000678	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Epirubicin—testicular cancer	0.000149	0.000676	CcSEcCtD
Olmesartan—Shock—Doxorubicin—testicular cancer	0.000149	0.000675	CcSEcCtD
Olmesartan—Nervous system disorder—Doxorubicin—testicular cancer	0.000149	0.000673	CcSEcCtD
Olmesartan—Thrombocytopenia—Doxorubicin—testicular cancer	0.000149	0.000672	CcSEcCtD
Olmesartan—Insomnia—Epirubicin—testicular cancer	0.000148	0.000671	CcSEcCtD
Olmesartan—Tachycardia—Doxorubicin—testicular cancer	0.000148	0.00067	CcSEcCtD
Olmesartan—Skin disorder—Doxorubicin—testicular cancer	0.000147	0.000667	CcSEcCtD
Olmesartan—Hyperhidrosis—Doxorubicin—testicular cancer	0.000147	0.000664	CcSEcCtD
Olmesartan—Anorexia—Doxorubicin—testicular cancer	0.000145	0.000654	CcSEcCtD
Olmesartan—Feeling abnormal—Methotrexate—testicular cancer	0.000144	0.000653	CcSEcCtD
Olmesartan—Dyspepsia—Epirubicin—testicular cancer	0.000144	0.000653	CcSEcCtD
Olmesartan—Gastrointestinal pain—Methotrexate—testicular cancer	0.000143	0.000648	CcSEcCtD
Olmesartan—Decreased appetite—Epirubicin—testicular cancer	0.000143	0.000645	CcSEcCtD
Olmesartan—Hypotension—Doxorubicin—testicular cancer	0.000142	0.000641	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Epirubicin—testicular cancer	0.000142	0.00064	CcSEcCtD
Olmesartan—Fatigue—Epirubicin—testicular cancer	0.000141	0.00064	CcSEcCtD
Olmesartan—Constipation—Epirubicin—testicular cancer	0.00014	0.000634	CcSEcCtD
Olmesartan—Pain—Epirubicin—testicular cancer	0.00014	0.000634	CcSEcCtD
Olmesartan—Urticaria—Methotrexate—testicular cancer	0.000139	0.00063	CcSEcCtD
Olmesartan—Abdominal pain—Methotrexate—testicular cancer	0.000138	0.000627	CcSEcCtD
Olmesartan—Body temperature increased—Methotrexate—testicular cancer	0.000138	0.000627	CcSEcCtD
Olmesartan—Musculoskeletal discomfort—Doxorubicin—testicular cancer	0.000138	0.000625	CcSEcCtD
Olmesartan—Insomnia—Doxorubicin—testicular cancer	0.000137	0.000621	CcSEcCtD
Olmesartan—Feeling abnormal—Epirubicin—testicular cancer	0.000135	0.000611	CcSEcCtD
Olmesartan—Gastrointestinal pain—Epirubicin—testicular cancer	0.000134	0.000607	CcSEcCtD
Olmesartan—Dyspepsia—Doxorubicin—testicular cancer	0.000134	0.000604	CcSEcCtD
Olmesartan—Decreased appetite—Doxorubicin—testicular cancer	0.000132	0.000597	CcSEcCtD
Olmesartan—Gastrointestinal disorder—Doxorubicin—testicular cancer	0.000131	0.000593	CcSEcCtD
Olmesartan—Fatigue—Doxorubicin—testicular cancer	0.000131	0.000592	CcSEcCtD
Olmesartan—Urticaria—Epirubicin—testicular cancer	0.00013	0.000589	CcSEcCtD
Olmesartan—Pain—Doxorubicin—testicular cancer	0.00013	0.000587	CcSEcCtD
Olmesartan—Constipation—Doxorubicin—testicular cancer	0.00013	0.000587	CcSEcCtD
Olmesartan—Abdominal pain—Epirubicin—testicular cancer	0.00013	0.000586	CcSEcCtD
Olmesartan—Body temperature increased—Epirubicin—testicular cancer	0.00013	0.000586	CcSEcCtD
Olmesartan—Asthenia—Methotrexate—testicular cancer	0.000126	0.000569	CcSEcCtD
Olmesartan—Feeling abnormal—Doxorubicin—testicular cancer	0.000125	0.000566	CcSEcCtD
Olmesartan—Gastrointestinal pain—Doxorubicin—testicular cancer	0.000124	0.000561	CcSEcCtD
Olmesartan—Pruritus—Methotrexate—testicular cancer	0.000124	0.000561	CcSEcCtD
Olmesartan—Urticaria—Doxorubicin—testicular cancer	0.000121	0.000545	CcSEcCtD
Olmesartan—Abdominal pain—Doxorubicin—testicular cancer	0.00012	0.000543	CcSEcCtD
Olmesartan—Body temperature increased—Doxorubicin—testicular cancer	0.00012	0.000543	CcSEcCtD
Olmesartan—Diarrhoea—Methotrexate—testicular cancer	0.00012	0.000542	CcSEcCtD
Olmesartan—Asthenia—Epirubicin—testicular cancer	0.000118	0.000532	CcSEcCtD
Olmesartan—Pruritus—Epirubicin—testicular cancer	0.000116	0.000525	CcSEcCtD
Olmesartan—Dizziness—Methotrexate—testicular cancer	0.000116	0.000524	CcSEcCtD
Olmesartan—Diarrhoea—Epirubicin—testicular cancer	0.000112	0.000508	CcSEcCtD
Olmesartan—Vomiting—Methotrexate—testicular cancer	0.000111	0.000504	CcSEcCtD
Olmesartan—Rash—Methotrexate—testicular cancer	0.00011	0.0005	CcSEcCtD
Olmesartan—Dermatitis—Methotrexate—testicular cancer	0.00011	0.000499	CcSEcCtD
Olmesartan—Headache—Methotrexate—testicular cancer	0.00011	0.000497	CcSEcCtD
Olmesartan—Asthenia—Doxorubicin—testicular cancer	0.000109	0.000493	CcSEcCtD
Olmesartan—Dizziness—Epirubicin—testicular cancer	0.000108	0.000491	CcSEcCtD
Olmesartan—Pruritus—Doxorubicin—testicular cancer	0.000107	0.000486	CcSEcCtD
Olmesartan—Vomiting—Epirubicin—testicular cancer	0.000104	0.000472	CcSEcCtD
Olmesartan—Nausea—Methotrexate—testicular cancer	0.000104	0.000471	CcSEcCtD
Olmesartan—Diarrhoea—Doxorubicin—testicular cancer	0.000104	0.00047	CcSEcCtD
Olmesartan—Rash—Epirubicin—testicular cancer	0.000103	0.000468	CcSEcCtD
Olmesartan—Dermatitis—Epirubicin—testicular cancer	0.000103	0.000467	CcSEcCtD
Olmesartan—Headache—Epirubicin—testicular cancer	0.000103	0.000465	CcSEcCtD
Olmesartan—Dizziness—Doxorubicin—testicular cancer	0.0001	0.000454	CcSEcCtD
Olmesartan—Nausea—Epirubicin—testicular cancer	9.74e-05	0.000441	CcSEcCtD
Olmesartan—Vomiting—Doxorubicin—testicular cancer	9.65e-05	0.000436	CcSEcCtD
Olmesartan—Rash—Doxorubicin—testicular cancer	9.57e-05	0.000433	CcSEcCtD
Olmesartan—Dermatitis—Doxorubicin—testicular cancer	9.56e-05	0.000432	CcSEcCtD
Olmesartan—Headache—Doxorubicin—testicular cancer	9.5e-05	0.00043	CcSEcCtD
Olmesartan—Nausea—Doxorubicin—testicular cancer	9.01e-05	0.000408	CcSEcCtD
